NCT00661427 · Interventional trial
Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Overall registry status Completed
Phase 2
Conditions Head and Neck, Squamous Cell Cancer
Delaware Valley sites
- Abramson Cancer Center University of Pennsylvania · Philadelphia, PA · Philadelphia County
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Pennsylvania Hospital · Philadelphia, PA · Philadelphia County
- University of Pennsylvania - Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory